Will Ashworth

Will Ashworth

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Over the Next Decade, These 10 Stocks Will Ride the ESG Investing Wave

Estimates suggest institutions will allocate more than $20 trillion in capital toward ESG investing. These 10 stocks ought to benefit. 

Has CEO Irwin Simon Earned His Keep at Aphria?

Aphria CEO Irwin Simon has been in the top job since March 2019. Aphria stock is down 54% since. Has the veteran executive earned his keep? 

Is Sunworks the Penny Stock of Your Dreams?

Sunworks is merging with Peck Company. SUNW stock will be exchanged for PECK shares. Here’s why you ought to be happy about the combination.  

10 Consumer Stocks for a Reliable Portfolio

Whether you want your consumer stocks to focus on discretionary items or staples, here are 10 of the best buys you can make right now.

It’s Time for Luckin Stock to Put Up or Shut Up

Luckin Coffee hasn't released a quarterly report for a year. Yet Luckin stock is up 80% in the past three months. What gives?  

Piedmont Lithium Stock Might Not Be Your Best Bet on the Metal

Piedmont Lithium recently raised $57.5 million selling 2.3 million shares. With no revenues, is Piedmont Lithium stock worth a gamble?  

Brookfield Renewable Brings Plug Power Much Needed Green Energy

Plug Power announced an energy supply agreement with Brookfield Renewable. Here’s why that’s good for both PLUG stock and BEP stock. 

7 Thematic Mutual Funds to Add Some Spice to Your Portfolio

Thematic mutual funds and ETFs have become popular in recent years. Here are seven to spice up your portfolio and will last the test of time.

Could the FDA Be Ready to Crash Inovio’s Hopes and Dreams?

It’s been a month since the FDA put Inovio’s Covid-19 vaccine on partial clinical hold. No news is definitely not good news for INO stock. 

America’s Love Affair With Solar Could Translate to Higher Sunrun Share Price

Americans are installing record amounts of solar panels on their homes. That’s good news for Sunrun. But is it good news for RUN stock?